Occidental Asset Management, LLC Halozyme Therapeutics, Inc. Transaction History
Occidental Asset Management, LLC
- $717 Million
- Q2 2025
A detailed history of Occidental Asset Management, LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Occidental Asset Management, LLC holds 7,742 shares of HALO stock, worth $496,262. This represents 0.06% of its overall portfolio holdings.
Number of Shares
7,742
Previous 6,086
27.21%
Holding current value
$496,262
Previous $388,000
3.61%
% of portfolio
0.06%
Previous 0.06%
Shares
2 transactions
Others Institutions Holding HALO
# of Institutions
609Shares Held
126MCall Options Held
408KPut Options Held
388K-
Black Rock Inc. New York, NY17.6MShares$1.13 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.2MShares$785 Million0.01% of portfolio
-
State Street Corp Boston, MA5.94MShares$380 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA3.47MShares$222 Million0.03% of portfolio
-
Snyder Capital Management L P San Francisco, CA3.4MShares$218 Million3.92% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $8.93B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...